Geode Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $63.3K | Sell |
|
|||||
|
2023
Q4 | $85.3K | Hold |
|
|||||
|
2023
Q3 | $116K | Buy |
|
|||||
|
2023
Q2 | $267K | Sell |
|
|||||
|
2023
Q1 | $707K | Buy |
|
|||||
|
2022
Q4 | $897K | Buy |
|
|||||
|
2022
Q3 | $5.55M | Buy |
|
|||||
|
2022
Q2 | $4.36M | Buy |
|
|||||
|
2022
Q1 | $5.28M | Buy |
|
|||||
|
2021
Q4 | $3.16M | Buy |
|
|||||
|
2021
Q3 | $4.06M | Buy |
|
|||||
|
2021
Q2 | $5.1M | Buy |
|
|||||
|
2021
Q1 | $4.96M | Buy |
|
|||||
|
2020
Q4 | $5.68M | Buy |
|
|||||
|
2020
Q3 | $3.19M | Buy |
|
|||||
|
2020
Q2 | $3.36M | Buy |
|
|||||
|
2020
Q1 | $2.21M | Buy |
|
|||||
|
2019
Q4 | $4.51M | Buy |
|
|||||
|
2019
Q3 | $3.01M | Buy |
|
|||||
|
2019
Q2 | $3.07M | Buy |
|
|||||
|
2019
Q1 | $1.72M | Buy |
|
|||||
|
2018
Q4 | $1.06M | Buy |
|
|||||
|
2018
Q3 | $931K | Hold |
|
|||||
|
2018
Q2 | $947K | Buy |
|
|||||
|
2018
Q1 | $227K | Hold |
|
|||||
|
2017
Q4 | $322K | Hold |
|
|||||
|
2017
Q3 | $253K | Hold |
|
|||||
|
2017
Q2 | $182K | Sell |
|
|||||
|
2017
Q1 | $368K | Buy |
|
|||||
|
2016
Q4 | $311K | Buy |
|
|||||
|
2016
Q3 | $355K | Buy |
|
|||||
|
2016
Q2 | $199K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $86K | Hold |
|
|||||
|
2015
Q3 | $61K | Hold |
|
|||||
|
2015
Q2 | $74K | Hold |
|
|||||
|
2015
Q1 | $1.11M | Buy |
|
|||||
|
2014
Q4 | $1.07M | Hold |
|
|||||
|
2014
Q3 | $570K | Buy |
|
|||||
|
2014
Q2 | $343K | Sell |
|
|||||
|
2014
Q1 | $307K | Buy |
|